Gabapentin

CHEMBL940 Phase 4 Approved Small molecule
Half-Life
5-7 hours
Bioavailability
Protein Binding
Molecular Weight
171.2 g/mol
LogP
-1.1
Phase
4

Originally developed as an anticonvulsant, gabapentin found its widest use in treating nerve pain. It binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing calcium entry at nerve terminals and thereby dampening the release of excitatory signals that carry abnormal or painful impulses. This action underlies its use in epilepsy, postherpetic neuralgia, and a range of other neuropathic pain conditions. A small molecule (C9H17NO2) structurally related to the neurotransmitter GABA, though it does not act directly on GABA receptors, it has a half-life of about 5 to 7 hours and is eliminated unchanged by the kidneys. Its renal clearance shapes dosing in people with reduced kidney function. Gabapentin is an approved medicine spanning seizure control and chronic pain.

This medication was originally developed as an anticonvulsant but is also widely used to treat nerve pain by modulating calcium channels in nerve cells to reduce abnormal electrical activity. It is prescribed for epilepsy, postherpetic neuralgia, and various other neuropathic pain conditions.

Molecular Weight

171.2370 g/mol

LogP

-1.10

TPSA

63.30 Ų

Lipinski RO5

Pass

Therapeutic Areas

Drug Classes

Mechanism of Action

Binds alpha-2-delta subunit of voltage-gated calcium channels.

Pharmacokinetics (PK)

Half-Life 5-7 hours

Pharmacodynamics (PD)

Mechanism

Binds alpha-2-delta subunit of voltage-gated calcium channels.

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NCC1(CC(=O)O)CCCCC1

InChI

InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)

Molecular Formula

C9H17NO2

HBD / HBA

2 / 3

Rotatable Bonds

3

Heavy Atoms

12

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This medication was originally developed as an anticonvulsant but is also widely used to treat nerve pain by modulating calcium channels in nerve cells to reduce abnormal electrical activity. It is prescribed for epilepsy, postherpetic neuralgia, and various other neuropathic pain conditions.

Binds alpha-2-delta subunit of voltage-gated calcium channels.

Key pharmacokinetic parameters for Gabapentin: Half-life: 5-7 hours.

Yes, Gabapentin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL940. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3446. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.